Invivo Therapeutics Holdings Corp Company Profile (OTCMKTS:NVIV)

About Invivo Therapeutics Holdings Corp

Invivo Therapeutics Holdings Corp logoInVivo Therapeutics Holdings Corp., formerly Design Source, Inc., is a research and clinical-stage biomaterials and biotechnology company. The Company is engaged in developing and commercializing biopolymer-scaffolding devices for the treatment of spinal cord injuries (SCI). The Company's approach to treating acute SCIs is based on its investigational Neuro Spinal Scaffold implant, an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord contusion and is intended to treat acute spinal cord injury. The Neuro-Spinal Scaffold consists of biocompatible and bioresorbable polymers, which include poly lactic-co-glycolic acid (PLGA) and Poly-L-Lysine (PLL). The Company is also evaluating other technologies and therapeutics that may be complementary to its development of the Neuro-Spinal Scaffold implant. The Company has a clinical development program for acute SCI and a preclinical development program for chronic SCI.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: OTCMKTS
  • Symbol: NVIV
  • CUSIP:
Key Metrics:
  • Previous Close: $6.73
  • 50 Day Moving Average: $6.80
  • 200 Day Moving Average: $6.59
  • 52-Week Range: $3.50 - $11.80
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -7.24
  • P/E Growth: 0.00
  • Market Cap: $214.87M
  • Outstanding Shares: 31,927,000
Additional Links:
Companies Related to Invivo Therapeutics Holdings Corp:

Analyst Ratings

Consensus Ratings for Invivo Therapeutics Holdings Corp (OTCMKTS:NVIV) (?)
Ratings Breakdown: 2 Buy Ratings, 1 Strong Buy Rating
Consensus Rating:Buy (Score: 3.33)
Consensus Price Target: $20.42

Analysts' Ratings History for Invivo Therapeutics Holdings Corp (OTCMKTS:NVIV)
Show:
DateFirmActionRatingPrice TargetDetails
7/21/2016Ladenburg ThalmannInitiated CoverageBuy$23.25View Rating Details
7/7/2016Raymond James Financial Inc.Initiated CoverageStrong-Buy$13.00View Rating Details
5/12/2016HC WainwrightReiterated RatingBuyView Rating Details
(Data available from 9/27/2014 forward)

Earnings

Earnings History for Invivo Therapeutics Holdings Corp (OTCMKTS:NVIV)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/2/2016        
8/4/2016Q2($0.22)($0.18)ViewN/AView Earnings Details
5/6/2016($0.26)($0.20)ViewN/AView Earnings Details
8/5/2015($0.20)($0.39)ViewN/AView Earnings Details
5/7/2015($0.05)($0.64)ViewN/AView Earnings Details
3/11/2015($0.04)($0.09)ViewN/AView Earnings Details
11/5/2014($0.05)($0.01)ViewN/AView Earnings Details
8/6/2014($0.06)($0.04)ViewN/AView Earnings Details
5/12/2014($0.08)($0.07)ViewN/AView Earnings Details
3/17/2014($0.08)($0.06)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Invivo Therapeutics Holdings Corp (OTCMKTS:NVIV)
Current Year EPS Consensus Estimate: $-0.80 EPS
Next Year EPS Consensus Estimate: $-0.93 EPS

Dividends

Dividend History for Invivo Therapeutics Holdings Corp (OTCMKTS:NVIV)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Invivo Therapeutics Holdings Corp (OTCMKTS:NVIV)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/9/2014Francis ReynoldsMajor ShareholderSell50,000$1.20$60,000.00View SEC Filing  
5/5/2014Francis ReynoldsMajor ShareholderSell37,500$1.87$70,125.00View SEC Filing  
4/30/2014Francis ReynoldsMajor ShareholderSell37,500$1.82$68,250.00View SEC Filing  
4/25/2014Francis ReynoldsMajor ShareholderSell50,000$1.52$76,000.00View SEC Filing  
4/21/2014Francis ReynoldsMajor ShareholderSell50,000$1.57$78,500.00View SEC Filing  
4/14/2014Francis ReynoldsMajor ShareholderSell37,500$1.63$61,125.00View SEC Filing  
4/9/2014Francis ReynoldsMajor ShareholderSell37,500$1.60$60,000.00View SEC Filing  
4/4/2014Francis ReynoldsMajor ShareholderSell25,000$1.71$42,750.00View SEC Filing  
4/2/2014Francis ReynoldsMajor ShareholderSell37,500$1.71$64,125.00View SEC Filing  
3/26/2014Francis ReynoldsMajor ShareholderSell47,900$1.80$86,220.00View SEC Filing  
3/21/2014Francis ReynoldsMajor ShareholderSell39,600$2.15$85,140.00View SEC Filing  
3/17/2014Francis ReynoldsMajor ShareholderSell37,500$2.44$91,500.00View SEC Filing  
3/12/2014Francis ReynoldsMajor ShareholderSell37,500$2.33$87,375.00View SEC Filing  
3/7/2014Francis ReynoldsMajor ShareholderSell25,000$2.44$61,000.00View SEC Filing  
3/5/2014Francis ReynoldsMajor ShareholderSell37,500$2.49$93,375.00View SEC Filing  
2/28/2014Francis ReynoldsMajor ShareholderSell25,000$2.44$61,000.00View SEC Filing  
2/26/2014Francis ReynoldsMajor ShareholderSell37,500$2.28$85,500.00View SEC Filing  
2/21/2014Francis ReynoldsMajor ShareholderSell25,000$2.23$55,750.00View SEC Filing  
2/19/2014Francis ReynoldsMajor ShareholderSell25,000$2.25$56,250.00View SEC Filing  
2/14/2014Francis ReynoldsMajor ShareholderSell25,000$2.24$56,000.00View SEC Filing  
2/12/2014Francis ReynoldsMajor ShareholderSell37,500$2.25$84,375.00View SEC Filing  
2/7/2014Francis ReynoldsMajor ShareholderSell25,000$2.23$55,750.00View SEC Filing  
2/5/2014Francis ReynoldsMajor ShareholderSell37,500$2.21$82,875.00View SEC Filing  
1/31/2014Francis ReynoldsMajor ShareholderSell25,000$2.17$54,250.00View SEC Filing  
1/29/2014Francis ReynoldsMajor ShareholderSell37,500$2.22$83,250.00View SEC Filing  
1/24/2014Francis ReynoldsMajor ShareholderSell25,000$2.25$56,250.00View SEC Filing  
1/21/2014Francis ReynoldsMajor ShareholderSell37,500$2.36$88,500.00View SEC Filing  
1/15/2014Francis ReynoldsMajor ShareholderSell37,500$2.22$83,250.00View SEC Filing  
1/10/2014Francis ReynoldsMajor ShareholderSell48,000$2.41$115,680.00View SEC Filing  
1/6/2014Francis ReynoldsMajor ShareholderSell36,000$2.28$82,080.00View SEC Filing  
12/31/2013Francis ReynoldsMajor ShareholderSell36,000$2.25$81,000.00View SEC Filing  
12/26/2013Francis ReynoldsMajor ShareholderSell36,000$1.99$71,640.00View SEC Filing  
12/20/2013Francis ReynoldsMajor ShareholderSell24,000$1.96$47,040.00View SEC Filing  
12/18/2013Francis ReynoldsMajor ShareholderSell36,000$1.90$68,400.00View SEC Filing  
12/13/2013Francis ReynoldsMajor ShareholderSell24,000$1.80$43,200.00View SEC Filing  
12/11/2013Francis ReynoldsMajor ShareholderSell36,000$1.75$63,000.00View SEC Filing  
12/6/2013Francis ReynoldsMajor ShareholderSell24,000$1.59$38,160.00View SEC Filing  
12/4/2013Francis ReynoldsMajor ShareholderSell36,000$1.90$68,400.00View SEC Filing  
11/22/2013Francis ReynoldsMajor ShareholderSell24,000$1.92$46,080.00View SEC Filing  
11/20/2013Francis ReynoldsMajor ShareholderSell36,000$1.95$70,200.00View SEC Filing  
11/13/2013Francis ReynoldsMajor ShareholderSell36,000$1.14$41,040.00View SEC Filing  
11/8/2013Francis ReynoldsMajor ShareholderSell24,000$1.11$26,640.00View SEC Filing  
11/6/2013Francis ReynoldsMajor ShareholderSell36,000$1.16$41,760.00View SEC Filing  
11/1/2013Francis ReynoldsMajor ShareholderSell24,000$1.16$27,840.00View SEC Filing  
10/30/2013Francis ReynoldsMajor ShareholderSell36,000$1.23$44,280.00View SEC Filing  
10/25/2013Francis ReynoldsMajor ShareholderSell24,000$1.35$32,400.00View SEC Filing  
10/22/2013Francis ReynoldsMajor ShareholderSell24,000$1.40$33,600.00View SEC Filing  
10/18/2013Francis ReynoldsMajor ShareholderSell24,000$1.45$34,800.00View SEC Filing  
10/16/2013Francis ReynoldsMajor ShareholderSell36,000$1.49$53,640.00View SEC Filing  
10/11/2013Francis ReynoldsMajor ShareholderSell24,000$1.51$36,240.00View SEC Filing  
10/9/2013Francis ReynoldsMajor ShareholderSell36,000$1.41$50,760.00View SEC Filing  
10/4/2013Francis ReynoldsMajor ShareholderSell24,000$1.41$33,840.00View SEC Filing  
9/20/2013Francis ReynoldsMajor ShareholderSell24,000$1.37$32,880.00View SEC Filing  
9/18/2013Francis ReynoldsMajor ShareholderSell36,000$1.43$51,480.00View SEC Filing  
9/13/2013Francis ReynoldsMajor ShareholderSell24,000$1.50$36,000.00View SEC Filing  
9/11/2013Francis ReynoldsMajor ShareholderSell24,000$1.72$41,280.00View SEC Filing  
9/6/2013Francis ReynoldsMajor ShareholderSell24,000$1.61$38,640.00View SEC Filing  
9/4/2013Francis ReynoldsMajor ShareholderSell24,000$1.36$32,640.00View SEC Filing  
9/3/2013Sean F MoranCFOBuy20,000$1.02$20,400.00View SEC Filing  
8/30/2013Francis ReynoldsMajor ShareholderSell9,200$1.55$14,260.00View SEC Filing  
8/30/2013Sean F MoranCFOBuy40,000$1.30$52,000.00View SEC Filing  
8/28/2013Francis ReynoldsMajor ShareholderSell12,600$3.24$40,824.00View SEC Filing  
8/23/2013Francis ReynoldsMajor ShareholderSell21,300$4.07$86,691.00View SEC Filing  
8/21/2013Francis ReynoldsCEOSell36,000$4.12$148,320.00View SEC Filing  
8/16/2013Francis ReynoldsCEOSell24,000$4.24$101,760.00View SEC Filing  
8/14/2013Francis ReynoldsCEOSell36,000$4.34$156,240.00View SEC Filing  
8/9/2013Francis ReynoldsCEOSell24,000$4.42$106,080.00View SEC Filing  
8/7/2013Francis ReynoldsCEOSell36,000$4.46$160,560.00View SEC Filing  
8/2/2013Francis ReynoldsCEOSell24,000$4.57$109,680.00View SEC Filing  
7/30/2013Francis ReynoldsCEOSell24,000$5.11$122,640.00View SEC Filing  
7/26/2013Francis ReynoldsCEOSell24,000$5.29$126,960.00View SEC Filing  
7/24/2013Francis ReynoldsCEOSell36,000$5.72$205,920.00View SEC Filing  
7/19/2013Francis ReynoldsCEOSell24,000$5.27$126,480.00View SEC Filing  
7/17/2013Francis ReynoldsCEOSell36,000$5.12$184,320.00View SEC Filing  
7/12/2013Francis ReynoldsCEOSell24,000$4.43$106,320.00View SEC Filing  
7/10/2013Francis ReynoldsCEOSell36,000$3.97$142,920.00View SEC Filing  
7/5/2013Francis ReynoldsCEOSell12,000$4.00$48,000.00View SEC Filing  
7/3/2013Francis ReynoldsCEOSell36,000$4.08$146,880.00View SEC Filing  
6/28/2013Francis ReynoldsCEOSell24,000$4.22$101,280.00View SEC Filing  
6/26/2013Francis ReynoldsCEOSell36,000$3.87$139,320.00View SEC Filing  
6/21/2013Francis ReynoldsCEOSell24,000$3.78$90,720.00View SEC Filing  
6/19/2013Francis ReynoldsCEOSell36,000$3.89$140,040.00View SEC Filing  
6/14/2013Francis ReynoldsCEOSell24,000$3.84$92,160.00View SEC Filing  
6/12/2013Francis ReynoldsCEOSell12,750$4.34$55,335.00View SEC Filing  
6/7/2013Francis ReynoldsCEOSell8,500$4.02$34,170.00View SEC Filing  
6/5/2013Francis ReynoldsCEOSell12,750$3.75$47,812.50View SEC Filing  
6/5/2013Robert LangerMajor ShareholderSell7,500$3.73$27,975.00View SEC Filing  
5/31/2013Francis ReynoldsCEOSell8,500$3.32$28,220.00View SEC Filing  
5/31/2013Robert LangerMajor ShareholderSell7,500$3.31$24,825.00View SEC Filing  
5/29/2013Francis ReynoldsCEOSell8,500$3.13$26,605.00View SEC Filing  
5/28/2013Robert LangerMajor ShareholderSell7,500$2.97$22,275.00View SEC Filing  
5/24/2013Francis ReynoldsCEOSell8,500$2.95$25,075.00View SEC Filing  
5/22/2013Robert LangerMajor ShareholderSell7,500$2.88$21,600.00View SEC Filing  
5/21/2013Francis ReynoldsCEOSell12,750$2.88$36,720.00View SEC Filing  
5/17/2013Francis ReynoldsCEOSell8,500$2.87$24,395.00View SEC Filing  
5/17/2013Robert LangerMajor ShareholderSell7,500$2.85$21,375.00View SEC Filing  
5/15/2013Francis ReynoldsCEOSell12,750$2.89$36,847.50View SEC Filing  
5/14/2013Robert LangerMajor ShareholderSell7,500$2.91$21,825.00View SEC Filing  
5/10/2013Francis ReynoldsCEOSell8,500$2.92$24,820.00View SEC Filing  
5/9/2013Robert LangerMajor ShareholderSell7,500$2.91$21,825.00View SEC Filing  
4/12/2013Francis ReynoldsCEOSell8,500$3.16$26,860.00View SEC Filing  
2/5/2013Francis ReynoldsCEOSell12,750$2.03$25,882.50View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Invivo Therapeutics Holdings Corp (OTCMKTS:NVIV)
DateHeadline
finance.yahoo.com logoInVivo Therapeutics to Present at Cell & Gene Meeting on the Mesa (OTCMKTS:NVIV)
finance.yahoo.com - September 26 at 11:10 AM
News IconWall Street Consensus Opinions for: InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) , Belden Inc (NYSE:BDC) - Wall Street Times (press release) (OTCMKTS:NVIV)
www.wallstreetnews24.com - September 23 at 11:13 AM
News IconInVivo Therapeutics Shares Rise 3%; to Give Late Breaking Presentation on Its Neuro-Spinal Scaffold (NASDAQ:NVIV) - Post News (OTCMKTS:NVIV)
www.kentuckypostnews.com - September 22 at 6:11 PM
News IconAnalyst Consensus Estimates & Projections are in For Shares of Invivo Therapeutics Holdings Corp (NYSE:NVIV) - Frisco Fastball (OTCMKTS:NVIV)
friscofastball.com - September 22 at 6:11 PM
businesswire.com logoInVivo Therapeutics Announces Late-Breaking Oral Presentation at the 2016 Congress of Neurological Surgeons ... - Business Wire (press release) (OTCMKTS:NVIV)
www.businesswire.com - September 22 at 6:11 PM
streetinsider.com logoInvivo Therapeutics (NVIV) to Make Late-Breaking Presentation on INSPIRE Trial at Congress of Neurological Surgeons (OTCMKTS:NVIV)
www.streetinsider.com - September 21 at 10:37 AM
News IconInVivo Therapeutics Announces Late-Breaking Oral Presentation at the 2016 Congress of Neurological Surgeons Annual Meeting (OTCMKTS:NVIV)
www.enhancedonlinenews.com - September 20 at 11:46 AM
News IconShares in Focus: Invivo Therapeutics Holdings Corp (NYSE:NVIV) Earnings & Targets Update - Frisco Fastball (OTCMKTS:NVIV)
friscofastball.com - September 14 at 10:47 AM
businesswire.com logoInVivo Therapeutics Announces Oral Platform Presentation at 2016 Congress of Neurological Surgeons Annual Meeting - Business Wire (press release) (OTCMKTS:NVIV)
www.businesswire.com - September 14 at 10:47 AM
finance.yahoo.com logoInVivo Therapeutics Announces Oral Platform Presentation at 2016 Congress of Neurological Surgeons Annual Meeting (OTCMKTS:NVIV)
finance.yahoo.com - September 14 at 10:46 AM
News IconJust Published: "InVivo Therapeutics Corporation - Medical Equipment - Deals and Alliances Profile" (OTCMKTS:NVIV)
reports.pr-inside.com - September 13 at 11:24 AM
News IconWall Street Analysts Watch-list: InVivo Therapeutics Holdings Corp ... - Wall Street Times (press release) (OTCMKTS:NVIV)
www.wallstreetnews24.com - September 12 at 6:13 PM
businesswire.com logoInVivo Therapeutics to Participate in Upcoming Investor Conferences - Business Wire (press release) (OTCMKTS:NVIV)
www.businesswire.com - September 7 at 10:04 AM
businesswire.com logoInVivo Therapeutics to Present at 55th International Spinal Cord Society Annual Scientific Meeting - Business Wire (press release) (OTCMKTS:NVIV)
www.businesswire.com - September 7 at 10:04 AM
finance.yahoo.com logoInVivo Therapeutics to Present at 55th International Spinal Cord Society Annual Scientific Meeting (OTCMKTS:NVIV)
finance.yahoo.com - September 7 at 10:04 AM
finance.yahoo.com logoInVivo Therapeutics to Participate in Upcoming Investor Conferences - Yahoo Finance (OTCMKTS:NVIV)
finance.yahoo.com - September 6 at 6:41 PM
publicnow.com logoInVivo Therapeutics to Participate in Upcoming Investor Conferences (OTCMKTS:NVIV)
www.publicnow.com - September 6 at 11:14 AM
News IconStock Struggling for the Quarter: InVivo Therapeutics Holdings Corp ... - Post News (OTCMKTS:NVIV)
www.kentuckypostnews.com - September 4 at 5:50 PM
kcregister.com logoNIKE, Inc. (NYSE:NKE) went down -0.41%: InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV), General Motors ... - KC Register (OTCMKTS:NVIV)
www.kcregister.com - August 29 at 6:21 PM
finance.yahoo.com logoNVIV: 5th Patient Conversion Supports Target Price Increase (OTCMKTS:NVIV)
finance.yahoo.com - August 23 at 6:44 PM
seekingalpha.com logoHas InVivo Therapeutics Developed A New Standard Of Spinal Cord Care? - Seeking Alpha (OTCMKTS:NVIV)
seekingalpha.com - August 23 at 10:58 AM
seekingalpha.com logoHas InVivo Therapeutics Developed A New Standard Of Spinal Cord Care? (OTCMKTS:NVIV)
seekingalpha.com - August 22 at 6:30 PM
News IconHot Biotech Stocks Recap: InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV), Corbus Pharmaceuticals Holdings ... - The Voice Registrar (OTCMKTS:NVIV)
voiceregistrar.com - August 20 at 10:38 AM
nasdaq.com logoNotable Thursday Option Activity: NVIV, GPS, TMO (OTCMKTS:NVIV)
www.nasdaq.com - August 19 at 6:29 PM
News IconShares Spotted Gapping Up Pre-Bell: InVivo Therapeutics Holdings Corp. (:NVIV) - Post News (OTCMKTS:NVIV)
www.kentuckypostnews.com - August 18 at 6:43 PM
News IconStock Moving Up in Trade: InVivo Therapeutics Holdings Corp. (:NVIV) - Post News (OTCMKTS:NVIV)
www.kentuckypostnews.com - August 18 at 6:43 PM
streetinsider.com logoInvivo Therapeutics (NVIV) Announces Additional AIS Grade Improvement in INSPIRE Study - StreetInsider.com (OTCMKTS:NVIV)
www.streetinsider.com - August 18 at 6:43 PM
News IconWhat Can Invivo Therapeutics Holdings Corp. (NASDAQ: NVIV) Achieve At This Rate? - Scibility Media (OTCMKTS:NVIV)
scibilitymedia.com - August 18 at 6:43 PM
News IconIndices Rally After FOMC Meeting (OTCMKTS:NVIV)
www.fxstreet.com - August 18 at 9:38 AM
streetinsider.com logoInvivo Therapeutics (NVIV) Announces Additional AIS Grade Improvement in INSPIRE Study (OTCMKTS:NVIV)
www.streetinsider.com - August 18 at 9:38 AM
publicnow.com logoInVivo Therapeutics Announces Northwestern Medicine as New Site for INSPIRE Study (OTCMKTS:NVIV)
www.publicnow.com - August 18 at 9:38 AM
News IconStock Gapping Up Pre-Market: InVivo Therapeutics Holdings Corp. (:NVIV) - Post News (OTCMKTS:NVIV)
www.kentuckypostnews.com - August 17 at 6:49 PM
News IconInVivo Therapeutics Announces Fifth Patient Conversion in INSPIRE Study of the Neuro-Spinal Scaffold (OTCMKTS:NVIV)
www.cbs58.com - August 17 at 9:37 AM
publicnow.com logoInVivo Therapeutics Announces Fifth Patient Conversion in INSPIRE Study of the Neuro-Spinal Scaffold™ (OTCMKTS:NVIV)
www.publicnow.com - August 17 at 9:37 AM
publicnow.com logoInVivo Therapeutics Appoints Pamela Stahl as Chief Commercial Officer (OTCMKTS:NVIV)
www.publicnow.com - August 11 at 9:46 AM
finance.yahoo.com logoNVIV: New Sites Announced, Trial Expansion Approved, Enrollees Needed. (OTCMKTS:NVIV)
finance.yahoo.com - August 9 at 6:49 PM
businesswire.com logoInVivo Therapeutics Reports 2016 Second Quarter Financial Results and Business Update - Business Wire (press release) (OTCMKTS:NVIV)
www.businesswire.com - August 6 at 9:23 AM
sg.finance.yahoo.com logoInVivo reports 2Q loss (OTCMKTS:NVIV)
sg.finance.yahoo.com - August 5 at 9:38 AM
marketwatch.com logo10-Q: INVIVO THERAPEUTICS HOLDINGS CORP. (OTCMKTS:NVIV)
www.marketwatch.com - August 4 at 6:57 PM
publicnow.com logoInVivo Therapeutics Reports 2016 Second Quarter Financial Results and Business Update (OTCMKTS:NVIV)
www.publicnow.com - August 4 at 6:57 PM
News IconHow Analysts Feel About Invivo Therapeutics Holdings Corp After Today's Huge Increase? - Consumer Eagle (OTCMKTS:NVIV)
www.consumereagle.com - July 22 at 6:26 PM
News IconLadenburg Thalmann Initiates Coverage on Invivo Therapeutics Holdings Corp to Buy - TheFounders Daily (OTCMKTS:NVIV)
www.thefoundersdaily.com - July 22 at 6:26 PM
4-traders.com logoInVivo Therapeutics : to Present at Cantor Fitzgerald's 2nd Annual Healthcare Conference (OTCMKTS:NVIV)
www.4-traders.com - July 22 at 9:30 AM
4-traders.com logoInVivo Therapeutics : Receives Investigational Testing Authorization from Health Canada (OTCMKTS:NVIV)
www.4-traders.com - July 21 at 6:51 PM
kcregister.com logoTop Stories: Sprint Corporation (NYSE:S), InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV), AT&T, Inc. (NYSE:T ... - KC Register (OTCMKTS:NVIV)
www.kcregister.com - July 20 at 7:18 PM
businesswire.com logoInVivo Therapeutics Announces Ben Taub Hospital/Baylor College of Medicine as New Site for INSPIRE Study - Business Wire (press release) (OTCMKTS:NVIV)
www.businesswire.com - July 18 at 6:40 PM
News IconTrading Spotlight - Shares on the Rise in Session: InVivo Therapeutics Holdings Corp. (:NVIV) - TGP (OTCMKTS:NVIV)
telanaganapress.com - July 18 at 6:40 PM
finance.yahoo.com logoInVivo Therapeutics Announces Ben Taub Hospital/Baylor College of Medicine as New Site for INSPIRE Study (OTCMKTS:NVIV)
finance.yahoo.com - July 18 at 8:00 AM
News IconShares Moving Down on the Week: InVivo Therapeutics Holdings Corp. (:NVIV) - Engelwood Daily (OTCMKTS:NVIV)
www.engelwooddaily.com - July 17 at 10:46 AM
News IconInvivo Therapeutics Holdings Cor (NASDAQ:NVIV) Shorted Shares Decreased By 15.03% - Consumer Eagle (OTCMKTS:NVIV)
www.consumereagle.com - July 17 at 10:46 AM

Social

Invivo Therapeutics Holdings Corp (OTCMKTS:NVIV) Chart for Tuesday, September, 27, 2016


Last Updated on 9/27/2016 by MarketBeat.com Staff